2020
DOI: 10.1080/14656566.2020.1759550
|View full text |Cite
|
Sign up to set email alerts
|

Capsaicin 8% dermal patch in clinical practice: an expert opinion

Abstract: Introduction: Neuropathic pain (NP) is caused by a lesion or disease of the somatosensory system, which can severely impact patients' quality of life. The current-approved treatments for NP comprise of both centrally acting agents and topical drugs, including capsaicin 8% dermal patches, which is approved for the treatment of peripheral NP. Areas covered: The authors summarize literature data regarding capsaicin use in patients who suffer from NP and discuss the clinical applications of this topical approach. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
20
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(22 citation statements)
references
References 63 publications
1
20
0
1
Order By: Relevance
“…This information may support the use of HCCPs earlier in the treatment journey even as a rst-line treatment option and is in line with current thinking about treatment algorithms for the treatment of focal neuropathic pain [32,33]. Consideration of a rst-line treatment with HCCP may be of special interest to the often poly-medicated post-surgical patients as systemic exposure to capsaicin is low and use of HCCP does not seem to lead to major drug interactions and systemic side effects often associated with oral pain treatments [34].…”
Section: Discussionsupporting
confidence: 53%
“…This information may support the use of HCCPs earlier in the treatment journey even as a rst-line treatment option and is in line with current thinking about treatment algorithms for the treatment of focal neuropathic pain [32,33]. Consideration of a rst-line treatment with HCCP may be of special interest to the often poly-medicated post-surgical patients as systemic exposure to capsaicin is low and use of HCCP does not seem to lead to major drug interactions and systemic side effects often associated with oral pain treatments [34].…”
Section: Discussionsupporting
confidence: 53%
“…For example, sensitivity to capsaicin is mediated by non-mechanosensory C fibers, while during heat perception, mostly mechanosensory C fibers and BC fibers are involved [29,222].…”
Section: Providing Solutions For Sensitive Skin: Neurocosmetic Ingredientsmentioning
confidence: 99%
“…While blocking of TRPV1 channels directly prevents Ca 2+ influx and subsequent signal transduction from sensory neurons, overactivation by agonists lead to internalization and subsequent desensitization of afferent nerve endings or degeneration of neurons by Ca 2+ -induced neurotoxicity [57]. Today, this therapeutic concept is used in form of transdermal application of high dose capsaicin for the treatment of neuropathic pain in the periphery [58]. Also, the local application of the highly potent agonist resiniferatoxin (RTX) as a "molecular scalpel" in the treatment of extensive pain (cancer) is under clinical trial [57].…”
Section: Expression Pattern Physiological Function and Pathophysiologymentioning
confidence: 99%